CD8A and tuberculosis: Aerosol delivery of an adenovirus TB vaccine candidate has been described as safe and induces enhanced polyfunctional airway responses, including CD8+ T cells, outperforming intramuscular delivery of the same vaccine in mouse models of Mtb challenge (349, 386) and a phase 1 human clinical trial (387).